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The appearance of birth defects after injection of heterologous antiserum directed 
against  whole rat  kidney homogenate into  pregnant  rats during  the organogenetic 
period  was  first  reported  by  Brent  and  his  colleagues  (I).  This  finding  has  been 
repeatedly  confirmed  and  extended  by  other  investigators  (2-6).  The  underlying 
mechanism  whereby  teratogenic  kidney  antiserum  induces  abnormal  embryonic 
development  is  not  understood,  although  the  responsible  teratogenic  agents  are 
immunoglobulin G  (7). It appears that the induction of congenital malformations by 
these immunoglobulins  (Ig) does not depend on complement and other nonspecific 
immunologic mediators (8). The rat kidney antigens that elicit the production of these 
teratogenic antibodies have not been isolated since the original finding in  1961 (1), 
although preliminary studies using both saline-soluble  (9)  and saline-insoluble  (10) 
kidney  fractions  indicated  that  the  responsible  antigens  are  glycoproteins of high 
molecular weights. This communication reports the isolation and partial characteri- 
zation of a highly purified glycoprotein antigen that elicited the production of potent 
teratogenic  antibodies.  Immunofluorescent studies  suggest  that  the  isolated  kidney 
antigen is a component of the proximal convoluted tubular cells. Furthermore, specific 
localization of the teratogenic antibodies  in vivo in the visceral yolk-sac endoderm 
and embryonic endoderm suggest that the teratogenic antibodies may induce abnor- 
mal embryonic development by interfering with the functions of the yolk-sac placenta 
or by a direct effect on the embryo itself. 
Materials and Methods 
Timing of Pregnancy.  A colony of random-bred Wistar rats was used. Rats were mated for 14 
h overnight. Females that had been inseminated were considered to be at the beginning of the 
1st d of pregnancy on the morning sperms were found. Rats were housed in stainless steel cages 
and given food (Purina mouse chow) and water ad lib. 
Extraction with Phosphate-buffered Saline (Step 1).  Purification of the glycoprotein that elicited 
the production of teratogenic antibodies involved six steps. Wistar rats of both sexes weighing 
200-350 g were perfused with isotonic phosphate-buffered saline (PBS),: pH 7.3. Kidneys were 
removed, decapsulated, and immediately frozen at -60°C. Each experiment used 100 kidneys, 
* Supported by U.S. Public Health Services Research grant HD13940 from the National Institutes of 
Health. 
1  Abbreviations used in this paper:  PBS, phosphate-buffered  saline, pH 7.3; Con A, concanavalin A; gp 
340K, rat renal tubular glycoprotein,  340,000 mol wt; PAGE, polyacrylamide  gel eleetrophoresis. 
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and the entire isolation procedure was performed in the cold at 4°C. Kidneys were homogenized 
in PBS (2 ml/kidney) containing 1 mM phenylmethylsulfonylfluoride,  10 mM N-ethylmaleim- 
ide, 25  mM e-aminoeaproic acid, and 20  mM EDTA in a  Virtis model 60K homogenizer 
(VirTis Co.,  Inc., Gardiner, NY)  at  10,000 rpm for 20  rain. The homogenate was  filtered 
through a stainless steel sieve (40 mesh) to remove large pieces of connective tissue and tissue 
debris. The filtrate was recovered and centrifuged at  105,000 g  for  1 h. The resultant clear 
supernatant was recovered. The residual pellet was extracted again with PBS containing the 
protease inhibitors, and the homogenate was centrifuged as described in the first extraction. 
The resultant supernatant was pooled with the supernatant obtained from the first extraction. 
Precipitation with Ammonium Sulfate  (Step  2).  The pooled supernatant was  adjusted with 
saturated ammonium sulfate solution to make a  60% solution of (NH4)2SO4 and allowed to 
equilibrate overnight. Protein precipitates were sedimented by centrifugation at 12,000 g. After 
discarding the supernatant, the precipitates were dissolved with a minimum amount of PBS. 
The protein solution was then dialyzed against PBS overnight and against 20  mM sodium 
phosphate buffer, pH 8.0, for 2 d with multiple changes of buffer. 
Anion Exchange Chromatography (Step 3).  The nondialyzable  material obtained by step 2 was 
concentrated to -25 ml by an Amicon ultrafiltration unit (Amicon Corp., Scientific Sys. Div., 
Lexington, MA) fitted with a PM 10 membrane. Anion exchange diethylaminoethyl  cellulose 
(DE 52)  was  obtained from Whatman Chemicals, Div. W  & R  Balston, Maidstone, Kent, 
England. Buffer equilibration,  removal of fines, and column packing were performed according 
to the instructions provided by the manufacturer. The cellulose was equilibrated with 20 mM 
phosphate buffer, pH 8.0.  A glass column with internal 25-ram Diam was packed with the 
equilibrated cellulose to a height of 300 ram. The concentrate from the Amicon uhrafihration 
unit was clarified by centrifugation at 12,000 g. The resultant supernatant was applied onto the 
DE 52 cellulose column. A flow rate of 30 ml/h was established. The absorbance of the effluent 
was determined at 280 nm using a Hitachi spectrophotometer (Hitachi Ltd., Tokyo, Japan). 
After the pass-through peak, a crude fraction was obtained by using one-step elution method 
with a solution of 0.2 M NaC1 without phosphate buffer. The eluted fraction thus obtained was 
subsequently dialyzed for 2 d  against 20 mM sodium phosphate buffer, pH  7.0, containing 
0.9% NaCI with several changes of buffer. 
Concanavalin A (Con A) Affinity Chromatography (Step 4).  The nondialyzable  material obtained 
by step 3 was concentrated to -25 ml by an Amicon ultrafihration unit fitted with a PM  10 
membrane. The concentrate was clarified by centrifugation at  12,000 g. The resultant super- 
natant was applied onto a Con A-Sepharose 4B column prepared as follows. Con A covalently 
bound to Sepharose 4B was obtained from Pharmacia Fine Chemicals, Div. of Pharmacia Inc., 
Uppsala, Sweden. 1 ml of packed Sepharose 4B contained ~ 10 mg of Con A. 10 ml of Con A- 
Sepharose 4B was equilibrated with 20 mM sodium phosphate buffer, pH 7.0, containing  0.9% 
NaCI and packed into a glass column (10 ×  100 mm). The equilibrated protein concentrate 
was allowed to pass through the Con A-Sepharose 4B column at a flow rate of 5 ml/h. The 
column was then washed with the same buffer until the absorption of the effluent at 280 nm 
decreased to almost the buffer level. The absorbed glycoproteins were eluted by the addition of 
the same buffer containing 100 mM a-methyl-D-mannoside. The eluted glycoproteins were 
dialyzed against 10 mM phosphate buffer containing 1 M  NaCI, pH 6.9, for 2 d with several 
changes of buffer. The nondialyzable glycoproteins were concentrated by an Amicon ultrafil- 
tration unit fitted with a PM 10 membrane. 
Sephacryl S-300 Gel Filtration (Step 5).  A glass column was packed with Sephacryl S-300 gel 
(Pharmacia Fine Chemicals, Div. of Pharmaeia Inc.) that had been equilibrated with 10 mM 
phosphate buffer containing 1 M NaC1, pH 6.9. The dimensions of the gel bed were 25 ×  920 
mm. The void volume of the column was determined by blue dextran 2,000.  Four proteins 
obtained from Pharmacia Fine Chemicals were used to calibrate the column: thyroglobulin 
(669,000 tool wt), ferritin (440,000 tool wt), aldolase (158,000 tool wt), and chymotrypsinogen 
A  (25,000 mol wt). After clarification by centrifugation, 5 ml of the glycoprotein concentrate 
obtained by step 4 was applied onto the column and allowed to pass through the column at a 
flow  rate of 20  ml/h.  The absorption of the effluent was  measured at  280  nm. Tubes of 
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buffer. The nondialyzable fractions were concentrated over Amicon PM  10 membrane and 
clarified by centrifugation. 
Discontinuous Polyac~lamide Gel Electrophoresis (PAGE)  (Step  6).  The dialyzed concentrates 
obtained by step 5 were analyzed and fractionated by discontinuous PAGE without sodium 
dodecyl sulfate. The procedure used was essentially the same as that described by Davis (11) 
but without the sample gel. 100-200 #g of protein samples were subjected to electrophoresis in 
5.25% separating gel. After adjustment to 15% (vol/vol) glycerol and 0.1% bromophenol blue, 
the samples were layered on top of a pH 6.9 spacer gel. Current of 1-2 mA per tube was used 
initially. After the samples had entered the spacer gel, the current was maintained at 7 mA per 
tube. At the completion of the electrophoretic run, the gels were removed from the tubes and 
rinsed with distilled water. They were frozen briefly and sliced into 2-3-ram segments. Duplicate 
gels were stained for proteins with 0.05% Coomassie Blue and for glycoproteins by the periodic 
acid-Sehiff procedure (12). Proteins were extracted from the unstained gel segments with PBS 
by homogenizing the identical segments from several gels in a small glass homogenizer. Protein 
fractions thus obtained were concentrated and analyzed again by disc PAGE. An apparent 
highly purified glycoprotein was isolated and designated as gp 340K. 
Isolation of Antibody-Antigen Complexes with Immobilized Protein A.  Protein A, obtained from the 
cell wall of Staphylococcus aureus, is known to interact with the Fc part of the IgG molecules of 
several  animal species, including rabbit. Rabbit IgG molecules were purified from the terato- 
genie antiserum directed against antigen gp 340K by precipitation at 33% ammonium sulfate 
saturation, pH 7.8, and subsequently by DE 52 ion-exchange cellulose equilibrated with 17.5 
mM phosphate buffer, pH 6.3. The rabbit IgG molecules were obtained from the pass-through 
peak of the DE 52 cellulose column, and their purity was monitored by disc PAGE. Protein A 
covalently coupled to Sepharose CL-4B was obtained from Pharmacia Fine Chemicals, which 
contained ~2 mg protein A per ml of Sepharose gel. After both the rabbit IgG molecules (20 
mg)  and protein A-Sepharose CL-4B  (3  ml) had been equilibrated with  10 mM phosphate 
buffer, pH 8.0,  the IgG molecules were allowed to absorb onto the immobilized protein A 
column. After the column had been extensively washed with PBS, 50 mg of PBS-soluble rat 
kidney supernatant obtained after centrifugation at  105,000 g  (step  1)  was allowed to pass 
through the column at a flow rate of 5 ml/h. The column was then washed with PBS until the 
absorbance at 280 nm reached almost the baseline (0.08) level. The immunocomplexes were 
eluted from the column by the addition of 0.58% glacial acetic acid containing 0.15 M  NaC1, 
pH 2.8, and were immediately dialyzed against several changes of PBS. The immunoprecipitates 
were recovered by centrifugation and stored at -10°C to be used as immunogens. 
Production of Antisera.  New Zealand white female rabbits weighing -2.5 kg each were used 
for the production of antisera by the method previously reported (13). Antisera were produced 
against the five protein fractions (A to E) obtained by Sephacryl S-300 gel filtration (step  5) 
and  against  proteins extracted  from  the  unstained gels  (step  6),  including the  gp  340K. 
Antiserum was also produced against the immunocomplexes obtained from the immobilized 
protein A  column. Protein concentration of the  antigens was  determined by  the  Bio-Rad 
protein assay (Bio-Rad Laboratories, Richmond, CA). A total of ~4 mg of protein each from 
various  fractions,  disc  PAGE  extractions,  and  immunocomplexes was  used  to  immunize 
individual  rabbits. Protein solutions  or immunocomplex  suspensions were emulsified with equal 
volume of complete  Freund's adjuvant  (Gibeo Laboratories,  Grand  Island Biological Co., 
Grand  Island,  NY).  Rabbits were  initially immunized once  in  the  footpads.  Subsequent 
subcutaneous multiple-site injections were given weekly for 6-7 wk. Rabbits were bled weekly 
from the central artery of the ear after the fourth injection. 1 wk after the last injection, the 
rabbits were exsanguinated by cardiac puncture. Sera from multiple bleedings were pooled, 
decomplemented at 56°C for 30 rain, and stored at -20°C. Antibody titers of the antisera were 
determined by serial dilutions, and immunoprecipitation  was observed by double immunodif- 
fusion in agar gel. Only antisera of high antibody titers were used. Control sera were obtained 
from the rabbits before immunization. 
Immunodiffusion.  Double immunodiffusion was performed in petri dishes containing 1.0% 
agar gel in PBS, pH 7.3. Merthiolate or NaN3 was added as a bacteriostatic agent. Each well 
was of 2-ram Diam. All wells were 5 mm from each other, center to center. The gel dishes were 
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precipitin lines had developed, the gels were removed and washed in PBS for 3 d, dried, and 
stained with  1% amido black for proteins. The Sudan black B staining method described by 
Barka and Anderson (14) was used to stain dried gel diffusion slides for lipoprotein antigens. 
After destaining in methanol, the precipitin lines were photographed. 
Immunoelectrophoresis.  The procedure was essentially the same as that described by Garvey 
and his colleagues (15). After electrophoresis of the antigenic protein solution in the center well, 
teratogenie antiserum  against  gp  340K  was  added  to  the  troughs.  After the  precipitation 
pattern had been developed, the slide was washed in PBS for 3 d with several changes of PBS. 
The slide was then dried, stained with 1% amido black, and photographed. 
Evaluation of Antisera  on  Emb~onic  Development.  The  biologic  effects  of the  antisera  on 
embryonic development were evaluated in the following manner. On the 9th d  of gestation, 
pregnant rats were injected intraperitoneally  with various dosages of antisera. Control pregnant 
rats were injected similarly with preimmunization rabbit serum. All rats were anesthetized with 
sodium pentobarbital (30 mg/kg) before intraperitoneal injection. The mothers were killed on 
the 22nd d  of gestation, and the fetuses were delivered by cesarean section. The fetuses were 
examined  grossly, weighed,  and  fixed  in  Bouin's  fixative  for  dissection.  The  incidence  of 
malformations was determined by the cross-sectional technique described by Wilson (16). Three 
9th d pregnant rats were injected with 0.5 ml of gp 340K antiserum per 100 g of animal weight 
and were killed 24 h later. Egg cylinders were subsequently dissected out from the uteri under 
a dissecting microscope, and individual lengths of the egg cylinders were measured. Control egg 
cylinders were likewise obtained from three pregnant rats injected with preimmunization rabbit 
serum and their measurements were recorded. 
Immunofluorescent Localization Studies.  After the intraperitoneal injection of the teratogenic 
antiserum directed against gp 340K into pregnant rats on the 9th d of pregnancy, the mothers 
were killed 24 or 48 h later. Maternal kidneys and embryonic tissues were examined for the in 
vivo localization of the injected antibodies with the direct fluorescent antibody technique as 
described previously (13).  Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit Ig 
was purchased from Calbiochem-Behring Corp., American Hoechst  Corp.,  San  Diego, CA. 
Absorption of the FITC-goat antibodies was performed twice by using  I00 mg of lyophilized 
Wistar  rat  liver  powder  per  ml  of reconstituted  FITC-goat  antibodies  for  1  h  at  room 
temperature. The absorbed FITC-goat antibodies were diluted 20-fold before use for staining. 
In vitro localization of antibodies in the rabbit antiserum directed against gp 340K was also 
performed on 4-/~m frozen sections of embryonic and kidney tissues obtained from untreated 
rats. The rabbit antiserum was twice absorbed with lyophilized rat liver powder and diluted 
20-fold before use for staining the tissue sections. Examination of the stained sections were 
made  using  a  Leitz  fluorescent  microscope  (E.  Leitz,  Inc.,  Rockleigh,  NJ)  with  an  XBO 
ultraviolet lamp. Photographs were taken with Kodak Tri-X (ASA 400)  film (Eastman Kodak 
Co., Rochester, NY). 
Results 
Isolation  and Characterization  of the Antigen.  The PBS-soluble rat kidney antigen was 
purified by ammonium  sulfate precipitation, DE  52 cellulose chromatography, Con 
A affinity column, Sephacryl S-300 gel filtration, and discontinuous PAGE. Sephacryl 
S-300 gel filtration resolved the glycoproteins eluted from the Con A  affinity column 
into five fractions (Fig. 1). The results of Coomassie Blue staining of disc PAGE gel of 
each  fraction  are  shown  in  Fig.  2.  All of the  protein  bands  in  each  fraction  were 
positive when stained with periodic acid-Schiff reagent. This result confirmed that all 
the proteins isolated by Con  A  affinity column  were glycoproteins. The Coomassie 
Blue-stained gels indicated that  peak A  contained large aggregates of proteins that 
could not  penetrate into the separating gel  (Fig.  2).  Peak B  contained  two  distinct 
glycoprotein  bands.  Peak  C  contained  one  major  broad  band  with  some  minor 
contamination from peak B. When antigens were extracted from regions b  and c  of 
the unstained gels B  and C  (Fig. 2)  with PBS and reelectrophoresed by disc PAGE, 376  TERATOGENIC GLYCOPROTEIN ANTISERUM 
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F[c.  1.  A representative  profile of Sephacryl S-300 gel filtration of the glycoproteins  eluted from 
the Con A affinity column. Vo indicates the void volume as determined by blue dextran 2,000. Five 
fractions (A to E) were obtained. 
the results indicated  that region b  contained  two distinct  bands  (not shown),  while 
one single band existed in region c (Fig. 3). The molecular weight of the major protein 
(gp 340K)  residing in peak C  of Sephacryl S-300 gel filtration was estimated to be 
-340,000.  This  glycoprotein  (gp  340K)  exhibited  an  a2-globulin  mobility  in  disc 
PAGE; it ran behind transferrin. However, the result of immunoelectrophoresis using 
PBS-soluble kidney supernatant  (step  1)  as the antigenic  solution  indicated  that  it 
had a  mobility between fla-globulin and a2-globulin. Ouchterlony diffusion analysis 
indicated that a single immunoprecipitin band was observed when gp 340K antiserum 
diffused against the crude PBS-soluble rat kidney homogenate (Fig. 4). This immu- 
noprecipitin  band  failed  to  stain  by  Sudan  black  B,  indicating  the  absence  of 
lipoprotein. A single immunoprecipitin line was also observed when antiserum to the 
immunocomplexes diffused against PBS-soluble rat kidney homogenate, and it was in 
complete identity with that formed by gp 340K antiserum. 
Evaluation of Effects of Antisera on Embryonic Development.  The results of testing for the 
biologic effects of the antisera against various fractions are summarized in Table I. 
The antisera against  the first  three peaks  (A, B, and C)  of the Sephacryl S-300  gel 
filtration (Fig. 1) demonstrated that they were all teratogenic, whereas antisera against 
antigens in peak D and E seemed to have little effect on embryonic development. The 
antisera against proteins extracted from the unstained disc gels (region b) of peak B 
did  not  seem to have any effect on embryonic development.  On  the contrary,  the 
antiserum  against  gp  340K extracted  from the  unstained  disc  gels  (region  c)  from 
peak C  was very potent embryotoxic agent. All the conceptuses were resorbed when 
the mothers were injected with 1 ml/100 g of animal weight. The antiserum induced 
birth defects in all of the surviving fetuses when injected with a dosage of 0.25 ml/100 
g of animal weight. The antiserum directed against  the immunocomplexes was also 
teratogenic:  injection of 1.0  ml of antiserum  per  100  g  rat  resulted  in >80%  of the 
surviving fetuses being malformed. All of the embryotoxic antisera tested in this study 
induced  fetal growth retardation,  congenital  malformations, and  embryonic death. 
The term fetuses whose mothers were injected with embryotoxic antisera had a much 
lower mean weight than those whose mothers were exposed to preimmunization sera. CHRISTOPHER C.  K.  LEUNG  377 
FIc. 2.  Discontinuous PAGE of the  five fractions (A to E)  obtained  by Sephacryl S-300 gel 
filtration.  Antigens were extracted  from unstained  segments marked  b  and  c  from  B and  C, 
respectively. 
Fxe.  3.  Reelectrophoresis by disc PAGE of the major glycoprotein (gp 340K) extracted  from c 
(Fig. 2). 
The  biologic  effects  of the  embryotoxic  antisera  appeared  to  be  dose  dependent. 
Defects such as anophthalmia,  hydrocephaly, exencephaly, cleft palate, cleft lip, and 
some cardiovascular anomalies were observed. Nevertheless the most common anom- 
aly  was  anophthalmia.  Some  of the  mothers  injected  with  lower  dosage  of the 
antiserum  were allowed to deliver their abnormal offspring.  Many of those with  no 
other major abnormalities  except  eye defects survived  and  grew up  to be  adults  of 
normal size and weight.  The effect of the antiserum  against  gp 340K on the growth 
of the embryos at the egg cylinder stage was apparent:  24 h  after the administration 
of the antiserum,  the  mean  size  (1.04  mm)  of 36 egg cylinders was almost  one-half 
that  (1.82 mm) of the 27 controls. 
In Vivo Localization of  Antibodies to Gp 340K.  Specific immunofluorescent localization 
of teratogenic  antibodies  against  gp  340K  was  observed  in  the  visceral  yolk  sac 
endodermal  cells  and  embryonic endoderm  of 10th  d  gestational  age,  that  is,  24  h 
after the administration of the antiserum  (Fig. 5).  Similar staining was also observed 
in the visceral yolk sac endodermal cells 48 h after the administration of  the teratogenic 378  TERATOGENIC  GLYCOPROTEIN  ANTISERUM 
Fro.  4.  Ouchterlony gel diffusion analysis. Peripheral wells contained antiserum against gp 340K. 
Central well contained PBS-soluble rat kidney homogenate supernatant (30 mg/ml). 
TABLE  I 
Effect of Antisera on Embryonic Development 
Rabbit antiserum 
ml anti-  Surviving fetuses 
Mean 
Number  serum/  Embry-  Percent  fetal 
of litters  100 g  onie re-  Num-  with  weight 
pregnant  sorption  ber  malfor-  at term 
rat  mations 
Egg cylin£1ers 
Num-  Mean 
ber  length 
Sephacryl  S-300  4 
peak A 
Sephacryl  S-300  5 
peak B 
Sephaeryl  S-300  5 
peak C 
Sephacryl  S-300  5 
peak D 
Sephacryl  S-300  5 
peak E 
Disc PAGE region b  4 
Disc PAGE region c:  2 
gp 340K  4 
3 
5 
5 
6 
3 
Immune.complexes 
Control  preimmuni- 
zation serum 
%  g 
1.0  17  44  100  3.28 
1.0  15  51  96  3.75 
1.0  10  43  100  3.24 
1.0  10  43  0  4.63 
1.0  8  59  2  4.70 
1.0  12  56  0  4.65 
1.0  100 
0.5  44  31  90  4.02 
0.5 
0.25  17  39  100  3.51 
1.0  15  57  86  3.29 
1.0  12  60  2  4.68 
1.0 
36 
27 
mTYt 
1.04 
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FIG.  5.  Specific immunofluorescent localization  of teratogenic gp 340K antibodies. The mother 
was injected with 0.5 ml of rabbit gp 340K antiserum on the 9th d of gestation. The embryonic sites 
were examined 24 h  later. The visceral yolk-sac endoderm (VE) is continuous with the embryonic 
endoderm  (EE)  at this stage of embryonic development. Both structures (VE and EE)  of the egg 
cylinder were stained. To the right of the VE was the ectoplacental cone that was not stained. X 75. 
FIG.  6.  Specific immunofluorescent localization  of rabbit  gp 340K antibodies.  The  mother was 
injected  with 0.5  ml antiserum on the 9th d  of gestation. Tissue was examined on the  1 lth d  of 
gestation. Granular staining was observed at  the apical  part  of the visceral yolk-sac endodermal 
cells (VE). At this stage of embryonic development, there was little or not staining in the embryonic 
endoderm. Maternal tissue is shown above the VE. ×  200. 380  TERATOGENIC  GLYCOPROTEIN ANTISERUM 
antiserum  (Fig. 6); granular staining was observed at the apical portion of the cells. 
Reichert's membrane  (the basal  lamina  of the  parietal  yolk sac)  was  not  stained. 
Furthermore, there was no antibody localization in the maternal kidney tissue. There 
was no immunofluorescent staining in the visceral yolk sac and embryonic endoderm 
obtained from control pregnant rats injected with preimmunization rabbit serum. 
In  Vitro Localization of Antibodies to Gp 340K.  Specific immunofluorescent staining 
was  observed  in  the  visceral  yolk-sac  endoderm  (Fig.  7)  of all  gestational  ages 
examined  (9th-20th  d)  and  in the embryonic endoderm of 10th d  gestational age. 
The staining appeared to be along the external plasma membrane of the cells. There 
was  no  staining  in  the  basal  lamina  and  mesenchyme  of the  visceral  yolk  sac, 
mesothelial cells lining the exocoelom, blood vessels,  Reichert's membrane, parietal 
yolk-sac ceils, or trophoblast cells. Specific fluorescent staining was observed in the 
proximal convoluted tubular cells of the rat kidney (Fig. 8). There was no staining in 
the renal glomeruli, blood vessels or other renal tissues. 
Discussion 
Since the discovery of this interesting model in which abnormal embryonic devel- 
opment can be induced by antibodies, little progress has been made in the past two 
decades  in  the  area  of identifying  the  antigen(s)  that  elicits  the  production  of 
monospecific teratogenic antibodies. This apparent slow progress was primarily caused 
by the inherent difficulties involved in this teratogenic model. There was no in vitro 
method to substitute the time-consuming bioassay using the incidence of malforma- 
tions  as  the  end  point.  To  purify  the  responsible  antigen(s),  every  fraction  or 
subfraction of separated proteins had to be injected into rabbits for several weeks to 
produce antisera. The resulting antisera  had  to be tested in time-pregnant  rats to 
determine which fraction or subfraction contained the responsible antigenic molecules. 
This procedure, involving the production of antisera and subsequent bioassay of the 
antisera, was the only method available. Further complicating the situation was the 
fact that some rabbits did not respond to antigenic stimulation as well as others; only 
antisera of proven high antibody titer could be used. It was not uncommon that an 
assay was not completed for 6 mo or more. 
Although there might be more than one kidney antigen that is responsible for the 
production of teratogenic antibodies, we isolated a  highly purified large molecular 
weight protein that elicited teratogenic antibody production. The molecule appeared 
to be a  glycoprotein because it interacted with Con A and was PAS positive. It was 
neither a  lipoprotein, because it was not stained by Sudan black B, nor a  glycoami- 
noglycan (data not shown)  when determined by the alcian blue method  (17). The 
molecular weight of the glycoprotein was estimated by gel filtration to be 340,000; 
the actual molecular weight might be somewhat lower than this because glycoproteins 
exhibit abnormal  behavior in  gel  filtration  (18).  The isolated molecule had  an  a2 
electrophoretic mobility in  disc  PAGE.  However, a  much  broader electrophoretic 
pattern  (ill-a2)  was  observed when crude PBS-soluble kidney supernatant  was  ex- 
amined  by immunoelectrophoresis.  It  is  possible  that  under  this  condition  the  gp 
340K might  be associated  with  other molecules with  a  slower mobility.  It  is  also 
possible that this molecule might exhibit microheterogeneity as a result of the loss of 
sialic acid, or it might be an aggregate of  smaller molecules. Preliminary data obtained CHRISTOPHER  C.  K. LEUNG  381 
FIO. 7.  In vitro lmmunotluorescent staming ol rabbtt gp 340K antibodies. Visceral yolk-sac  tissue 
was obtained at the 14th d of  gestation. Staining appeared to be along the apical plasma membrane 
of the visceral yolk-sac endodermal cells; some cytoplasmic staining was also observed. Similar 
staining was observed on the visceral yolk-sac  tissue obtained at the 9th to 20th d of gestation. 
× 150. 
from preparative isoelectric focusing of the fraction eluted  from the (]on A  column 
(step 4) suggested that the gp 340K had isoelectric points ranging from 5.6 to 6.4. 
Edgington  and  his  colleagues  (19,  20)  isolated  three  rat  renal  tubular  epithelial 
antigens.  RTEoca and  RTEoq  (19)  were soluble only after treatment  with  sodium 
deoxycholate; RTEoq, a  nephritogenic lipoprotein antigen, was not associated with 
saline soluble fraction (20). Using pronase treatment, Naruse and his colleagues (21) 
isolated a rat renal tubular glycoprotein that was also nephritogenic. It is difficult to 
relate our gp 340K with the antigens isolated by the latter two groups of investigators 
because different methods were used. The gp 340K was saline soluble, and it was also 
present  in  the  saline-insoluble  fraction  (10);  it  was  isolated  without  using  any 
detergents or enzymes. It is possible that the gp 340K and those antigens isolated by 
Edgington  et  al. and Naruse et al.  might contain  some common antigenic determi- 
nants. 
The  mechanism  of  action  of  teratogenic  antibodies  is  not  understood.  Three 
hypotheses have been proposed (22). They are (a) secondary effect due to immunologic 
disease of the mother, (b) a  direct effect of antibodies on the embryo proper, and  (c) 
yolk sac placenta dysfunction. 
The first hypothesis assumes that  birth defects are the results of maternal immu- 
nologic  disease.  For  example,  heterologous  antiserum  directed  against  rat  kidney 
homogenate is known to be nephrotoxic  (23)  and would induce "Masugi" nephritis 
that resembles the pathology of human glomerulonephritis. Strong evidence has been 
presented (13, 24) to SUl~port the view that teratogenicity and nephrotoxicity of kidney 
antisera are of separate biologic properties. The nephrotoxicity of the antisera did not 
parallel their teratogenicity (13, 24). The result of our present investigation on the in 382  TERATOGENIC GLYCOPROTEIN ANTISERUM 
Fro. 8.  In vitro immunofluorescent staining of rabbit gp 340K antibodies on the rat renal tubular 
cells. Cytoplasmic staining of the tubular cells was observed. The nuclei were not stained. The 
glomeruli and blood vessels were not stained. × 150. 
vivo immunofluorescent localization of teratogenic gp 340K antibodies indicated that 
the  antibodies  did  not  localize in  the  maternal  kidney.  This  finding adds  further 
support  to the contention that  birth  defects  induced by antibodies  may not  result 
from maternal kidney immunologic disease but does not exclude the possibility that 
malformations could result from other maternal immunologic disease. 
The  question  whether  heterologous gp  340K  antibodies  ever reach  the  embryo 
during  the  period  of organogenesis  is  of obvious  importance.  Immunofluorescent 
localization studies demonstrated that gp 340K antibodies localized in the embryonic 
endoderm as well as the visceral yolk-sac endoderm at the  10th d  of gestation. The 
importance of antibody localization in the embryonic endoderm related to embryonic 
development  cannot  be  ignored,  although  such  localization  could  no  longer  be 
observed in embryos of later stages. The consistent localization of gp 340K antibodies 
in the visceral yolk-sac endodermal cells  from the  10th d to  12th d of gestation may 
play an important role in inducing abnormal embryonic development. The fixation 
of gp 340K antibodies in  the visceral yolk-sac endodermal cells  may interfere  with 
normal transport or histiotrophic functions of visceral yolk-sac epithelium because the 
rat visceral yolk sac has been regarded as an organ for active transport of nutrient to 
the embryo as well as respiratory exchange between the mother and the conceptus, 
especially before the establishment  of the chorioallantoic placenta on the  12th d  of 
gestation. 
It is conceivable that one might be able to induce rats or mice to produce teratogenic 
autoantibodies  after  injections  of  large  amounts  of  gp  340K.  Johnson  and  his 
colleagues (25)  recently reported  that rats, when injected with mouse nerve-growth 
factor, produced antibodies that reached the developing offspring and resulted in the CHRISTOPHER C. K. LEUNG  383 
destruction  of dorsal  root  ganglion  neurons.  Experiments  of this  nature  are being 
considered. 
Summary 
A  glycoprotein with an apparent 340,000 mol wt (gp 340K)  was isolated from rat 
kidney saline-soluble extract by ammonium sulfate precipitation, DE 52 ion-exchange 
cellulose  chromatography,  concanavalin  A  affinity  column,  Sephacryl  S-300  gel 
filtration, and discontinuous polyacrylamide gel electrophoresis (PAGE). The relative 
purity of gp 340K was examined by double immunodiffusion analysis, disc PAGE, 
and immunoelectrophoresis. Injection of rabbit gp 340K antiserum into pregnant rats 
during  the  organogenetic  period  induced  abnormal  embryonic  development,  fetal 
growth retardation, and embryonic death. Antiserum against the immunocomplexes 
isolated by immobilized protein A  also produced the same embryotoxic effects. The 
biologic  effects  of  the  antisera  appeared  to  be  dose  dependent.  Defects  such  as 
anophthalmia, hydrocephaly, exencephaly, cleft palate, cleft lip, and some cardiovas- 
cular  anomalies  were  observed.  The  most  frequently  observed  anomaly  was  an- 
ophthalmia.  Immunofluorescent  localization  studies  indicated  that  gp  340K  anti- 
bodies localized in vivo in the visceral yolk-sac endodermal cells and the embryonic 
endoderm. In vitro immunofluorescent localization studies revealed that gp 340K was 
a component of the renal tubular cells that cross-reacted with antigen in the visceral 
yolk-sac endodermal  cells  and  embryonic  endoderm.  The  underlying  mechanism 
whereby gp  340K  antibodies  induce  birth  defects  is  not  known.  Three  hypotheses 
were discussed. 
The author thanks Miss Sherry Hong for her excellent  technical assistance  and Mrs.  Gloria 
Marshall for typing the manuscript. 
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